iTeos Therapeutics, Inc.
ITOS · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $324 | $0 | $302 |
| Gross Profit | $0 | -$324 | -$34,388 | -$302 |
| % Margin | – | – | – | – |
| R&D Expenses | $57,275 | $29,039 | $37,523 | $36,686 |
| G&A Expenses | $10,181 | $10,982 | $11,809 | $12,112 |
| SG&A Expenses | $10,181 | $10,982 | $11,809 | $12,112 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $16,335 | $0 | $0 | $0 |
| Operating Expenses | $83,791 | $40,021 | $49,332 | $48,798 |
| Operating Income | -$83,791 | -$40,021 | -$49,332 | -$48,798 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $6,732 | $6,508 | $12,975 | $5,683 |
| Pre-Tax Income | -$77,059 | -$33,513 | -$36,357 | -$43,115 |
| Tax Expense | $1,670 | $607 | $7,355 | $2,243 |
| Net Income | -$78,729 | -$34,613 | -$43,712 | -$45,358 |
| % Margin | – | – | – | – |
| EPS | -1.81 | -0.8 | -1.08 | -1.05 |
| % Growth | -126.3% | 25.9% | -2.9% | – |
| EPS Diluted | -1.81 | -0.8 | -1.08 | -1.05 |
| Weighted Avg Shares Out | 43,565 | 43,241 | 40,474 | 43,135 |
| Weighted Avg Shares Out Dil | 43,565 | 43,241 | 40,474 | 43,135 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,382 | $6,950 | $7,659 | $8,010 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $340 | $324 | $322 | $302 |
| EBITDA | -$66,181 | -$33,682 | -$47,777 | -$47,693 |
| % Margin | – | – | – | – |